Search Data Variables

Indicates variations in the patient's weight over time. 5% or more lost in the last 30 days; 10% or more lost in the last 180 days. 

Indicates the patient is given intravenous (IV) fluids or hyperalimentation continuously or intermittenly. 

Indicates the presence of any type of tube that can deliver food/nutritional substance/fluids/medicates directly into the gastrointerstinal system. 

The patient's birthdate.

A record of the proportion of calories received and the average fluid intake, through parenteral or tube feeding in the last seven days. 

The actual amount of fluid the patient received by IV or tube feeding in the last seven days. 

A count of the number of stage 1 ulcers, regardless of cause, on any part of the body. Stage 1 is defined as a persistent area of skin redness (without a break in the skin) that does not disappear when pressure is relieved.

A count of the number of stage 2 ulcers, regardless of cause, on any part of the body. Stage 2 is defined as a partial thickness loss of skin layer that presents clinically as an abrasion, blister, or shallow crater. 

A count of the number of stage 3 ulcers, regardless of cause, on any part of the body. Stage 3 is defined as a full thickness loss of skin layers exposing the subcutaneous tissues. Presents as a deep crater with or without undermining adjacent tissue. 

A count of the number of stage 4 ulcers, regardless of cause, on any part of the body. Stage 4 is defined as a full thickness of skin and subcutaneous tissues is lost, exposing muscle or bone. 

A determination of the highest stage for pressure ulcers that were present in the last 7 days.

The presence of second or third degree burns from any cause (heat, chemicals) in any stage of healing. 

The presence of open lesions other than ulcers, rashes, cuts. Examples include lesions such as cancer lesions. 

The presence of healing and non-healing, open or closed surgical incisions, skin grafts or drainage sites on any part of the body. This category does not include healed surgical sites or stomas. 

This variable is an indicator as to whether or not the pharmacy offers some level of 340B service.

The 340B Program offers eligible safety net health care providers access to low-cost medications. Pharmacies must register to participate in this program.

Indicates the patient has received pressure relieving device(s) for the chair to manage skin problems in the past seven days. Includes gel, air, or other cushioning placed on a chair or wheelchair. 

Indicates the patient has received pressure relieving device(s) for the bed to manage skin problems in the past seven days. Includes air fluidized, low air loss therapy beds, flotation, water, or bubble mattress or pad placed on the bed. 

Indicates the patient has received turning/repositioning program to manage skin problems in the past seven days. Includes a continuous, consisten program for changing the patient's position and realigning the body. 

Indicates the patient has received nutrition or hydration intervention to prevent or treat specific skin conditions in the past seven days. Includes wheat-free diet to prevent allergic dermatitis, high calorie diet with added supplements to prevent skin breakdown, high protein supplements for wound healing. 

Indicates the patient has received any intervention for treating an ulcer at any ulcer stage in the past seven days. Includes use of dressings, chemical or surgical debridement, wound irrigations, and hydrotherapy. 

Indicates the patient has received any intervention for treating or protecting any type of surgical wound in the last seven days. Includes topical cleaning, wound irrigation, application of antimicrobial ointments, dressings of any type, suture removal, and warm soaks or heat application. 

Indicates the patient has had dressings applied with or without topical medications to treat a skin condition in the past seven days. Includes dry gauze dressings, dressings moistened with saline or other solutions, transparent dressings, hydrogel dressings, and dressings with hydrocolloid or hydroactive particles. 

Indicates the patient has had ointments or medications applied to treat a skin condition in the past seven days. Includes cortisone, antifungal preparations, chemoterapeutic agents, etc. 

This field groups (or recodes) the NDI ICD-10 code cause of death into 358 categories. The list reflects 358 selected causes of death.

Indicates the patient has a foot infection during the past seven days. Examples include cellulitis, purulent drainage. 

Indicates the patient has open foot lesions during the past seven days. Includes cuts, ulcers, and fissures. 

Indicates the patient has dressings with or without topical medication applied on the foot during the past seven days. Includes dry gauze dressings, dressings moistened with saline or other solutions, transparent dressings, hydrogel dressing, and dressings with hydrocolloid or hydroactive particles. 

Identifies those periods of a typical morning (over the last seven days) when the patient was awake all or most of the time (not more than one hour nap during any such period). 

Identifies those periods of a typical afternoon (over the last seven days) when the patient was awake all or most of the time (not more than one hour nap during any such period). 

Identifies those periods of a typical evening (over the last seven days) when the patient was awake all or most of the time (not more than one hour nap during any such period). 

A determination of the number of days during the past seven days that the patient received any type of medication, antigen, vaccines (including influenza and pneumovax), and/or PPD tests, by subcutaneous, intramuscular or intradermal injection. 

Indicates the patient received any type of chemotherapy given by any route. 

Indicates the patient received dialysis. Includes peritoneal and renal dialysis.

Indicates the patient received IV medication. Includes any drug or biological given by intravenous push or drip through a central or peripheral port. 

Indicates the patient received oxygen therapy. Includes continuous or intermitten oxygen via mask, cannula, etc. 

Indicates the patient receive oxygen therpay.  Includes continuous or intermittent oxygen via mask, cannula, etc.

Indicates the patient received radiation. Includes radiation therapy or having a radiation implant. 

Indicates the patient received suctioning. Includes nasopharyngeal or tracheal aspiration. 

Indicates the patient received tracheostomy care. Includes cleansing of tracheostomy and cannula. 

Indicates the patient received transfusions. Includes transfusions of blood or any blood products which are administered directly into the bloodstream. 

Indicates the patient received ventilator or respirator treatment. Includes any type of electrically or pneumatically powered closed system mechanical ventilatory support devices. 

Indicates the number of days speech language pathology and audiology therapy the patient received in the last seven days.

Indicates the total number of minutes of speech language pathology and audiology therapy the patient received during the past seven days. 

Indicates the number of days of occupational therapy received by the patient for the past seven days. 

Indicates the total number of minutes of occupational therapy received by the patient for the past seven days.

Indicates the number of days of physical therapy received by the patient for the past seven days. 

Indicates the total number of minutes of physical therapy received by the patient for the past seven days. 

Indicates the number of days of respiratory therapy received by the patient for the past seven days. 

Indicates the total number of minutes of respiratory therapy received by the patient for the past seven days. 

Indicates the extent to which the patient received passive range of motion nursing rehabilitation intervention. Range of motion exercise is a program of passive movements to maitain flexibility and useful motion in the joints of the body. The caregiver moves the body part around a fixed point or joint through the patient's available range of motion.